Annotation Detail for SGMS2
Basic Information
Top
Pathway ID | Pathway Name |
---|
| Metabolism of lipids and lipoproteins |
Pathway ID | Pathway Name |
---|
500824 | Sphingolipid metabolism |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SGMS2 mRNA | affects expression | 17562736
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of SGMS2 mRNA | increases expression | 18687144
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SGMS2 mRNA | decreases expression | 19150397
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SGMS2 mRNA | increases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SGMS2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SGMS2 mRNA | affects binding|increases activity|increases expression | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.45 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.40 | 3084413 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.77 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.35 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.63 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.63 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.66 | 16393943 19416960 11743745 16781746 12153990 11461765 12540782 16109766 11739529 11287661 19164858 18071297 19085960 17906064 19420014 16081117 14986274 18713872 12594235 10663392 10774834 19739265 12958197 10915739 2444490 12705907 14550746 14725611 11421492 16177239 17522070 15619225 19370779 11834606 17562736 11529661 15968718 16485898 19923254 12392966 16227642 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.71 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.82 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.82 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.62 | 12639820 12168785 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.29 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 19176532 16221962 19772884 18467677 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.99 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.41 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.41 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 19784758 12969438 11587558 16611625 19460945 19014921 12587719 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.58 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.92 | 15890375 16377806 20007298 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.50 | 17365036 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.05 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.30 | 16966607 16166281 18303189 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 18481113 19348381 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.18 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.69 | 16870215 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.38 | 10923243 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.14 | 17365031 17322281 17975199 15814490 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.38 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00122 |
- |
Choline |
Dietary supplement;Micronutrient;Nootropic Agents;Lipotropic Agents |